Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

7.76
Delayed Data
As of Jun 23
 -0.12 / -1.52%
Today’s Change
4.83
Today|||52-Week Range
9.71
+0.26%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close7.88
Today’s open7.88
Day’s range7.73 - 8.18
Volume771,343
Average volume (3 months)137,499
Market cap$262.8M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+16.15%
Earnings growth (this year)+15.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+31.48%
P/E ratioNM
Price/Sales3.43
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd-0.23-3.31%
CLDXCelldex Therapeutics...+0.04+1.55%
OXFDOxford Immunotec Glo...+0.45+2.93%
TRIBTrinity Biotech PLC-0.05-0.85%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 17, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$65.1M
Annual profit (last year)-$31.4M
Net profit margin-48.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Bonnie H. Anderson
President &
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts